Turnstone Biologics Corp. operates as a clinical stage biotechnology company. It engages in the business of developing and commercializing therapeutics. The company is focused on developing new medicines to treat and cure patients with solid tumors. Turnstone Biologics was founded in 2015 and is headquartered in La Jolla, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
14
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Turnstone Biologics Corp market cap is $8.21M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Turnstone Biologics Corp 52 week high is $0.8085 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Turnstone Biologics Corp 52 week low is $0.29 as of November 22, 2026.
Turnstone Biologics Corp stock price today is $0.3578.
Turnstone Biologics Corp stock price yesterday was $0.35.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Turnstone Biologics Corp's P/E ratio is -0.17.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Turnstone Biologics Corp P/B ratio is 0.5564.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Turnstone Biologics Corp 50-day moving average is $0.3578.